English
page_banner

Pwodwi yo

2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one Cas:1044871-04-6 Features Imaj
  • 2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one Cas:1044871-04-6

2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one Cas:1044871-04-6

Deskripsyon kout:

Nimewo Katalòg: XD90961
Cas: 1044871-04-6
Fòmil molekilè: C24H29N3O4
Pwa molekilè: 423.5
Disponibilite: Nan stok
Pri:  
Prepake:  
Pake an gwo: Mande Quote

 


Pwodwi detay

Tags pwodwi

Nimewo Katalòg XD90961
Non pwodwi 2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one

CAS

 1044871-04-6

Fòmil molekilè

 C24H29N3O4

Pwa molekilè

 423.5
Detay Depo  
Kòd Tarif Amonize  

 

Spesifikasyon pwodwi

Aparans  
Esè  
Bpwen lwil oliv 612.6±65.0 °C (Prevwa)
Dansite 1.25±0.1 g/cm3 (Prevwa)
Koyefisyan asidite (pKa)9.54±0.20(Prevwa)

 

RVX-297 se yon trè pisan, oralman aktif BET inhibitor selektif pou BD2.IC50s RVX-297 pou BRD2(BD2), BRD3(BD2), ak BRD4(BD2) te 0.08, 0.05, ak 0.02 μM, respektivman.RVX-297 inibit ekspresyon plizyè jèn selil iminitè enflamatwa.Efikasite RVX-297 nan modèl preklinik nan enflamasyon egi ak otoiminite.

  • Previous:
  • Pwochen:
    • Fèmen

    2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one Cas:1044871-04-6

    pwodwi ki gen rapò